{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:59:40Z","timestamp":1790135980720,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10096-023-04577-x","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T19:23:50Z","timestamp":1677007430000},"page":"431-439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Rapid diagnostics and ceftazidime\/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-2716","authenticated-orcid":false,"given":"Matteo","family":"Boattini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Charrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Comini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Giuseppe","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"4577_CR1","doi-asserted-by":"crossref","unstructured":"Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL, European survey of carbapenemase-producing enterobacteriaceae (EuSCAPE) working group (2015) Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill 20 pii=30062","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062"},{"key":"4577_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M et al (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785\u2013796","journal-title":"Lancet Infect Dis"},{"key":"4577_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/1469-0691.12697","volume":"20","author":"LS Tzouvelekis","year":"2014","unstructured":"Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL (2014) Treating infections caused by carbapenemase-producing enterobacteriaceae. Clin Microbiol Infect 20:862\u2013872","journal-title":"Clin Microbiol Infect"},{"key":"4577_CR4","doi-asserted-by":"publisher","first-page":"1800159","DOI":"10.2807\/1560-7917.ES.2019.24.5.1800159","volume":"24","author":"S Iacchini","year":"2019","unstructured":"Iacchini S, Sabbatucci M, Gagliotti C, Rossolini GM, Moro ML, Iannazzo S et al (2019) Bloodstream infections due to carbapenemase-producing enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017. Euro Surveill 24:1800159. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.5.1800159","journal-title":"Euro Surveill"},{"key":"4577_CR5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s10096-021-04192-8","volume":"40","author":"M Boattini","year":"2021","unstructured":"Boattini M, Bianco G, Iannaccone M, Ghibaudo D, Almeida A, Cavallo R et al (2021) Fast-track identification of CTX-M-extended-spectrum-\u03b2-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departments. Eur J Clin Microbiol Infect Dis 40:1495\u20131501. https:\/\/doi.org\/10.1007\/s10096-021-04192-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4577_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2147\/IDR.S206323","volume":"12","author":"B Fiori","year":"2019","unstructured":"Fiori B, D'Inzeo T, Posteraro B, Menchinelli G, Liotti FM, De Angelis G et al (2019) Direct use of eazyplex\u00ae SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections. Infect Drug Resist 12:1055\u20131062. https:\/\/doi.org\/10.2147\/IDR.S206323","journal-title":"Infect Drug Resist"},{"key":"4577_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhin.2021.01.015","volume":"110","author":"G Bianco","year":"2021","unstructured":"Bianco G, Boattini M, Iannaccone M, Pastrone L, Bondi A, Peradotto M et al (2021) Integrating rapid diagnostics in Gram-negative bloodstream infections of patients colonized by carbapenemase-producing Enterobacterales. J Hosp Infect 110:84\u201388. https:\/\/doi.org\/10.1016\/j.jhin.2021.01.015","journal-title":"J Hosp Infect"},{"key":"4577_CR8","first-page":"30524e5","volume":"S1198e743X","author":"DR Giacobbe","year":"2019","unstructured":"Giacobbe DR, Giani T, Bassetti M, Marchese A, Viscoli C, Rossolini GM (2019) Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications. Clin Microbiol Infect S1198e743X:30524e5","journal-title":"Clin Microbiol Infect"},{"key":"4577_CR9","doi-asserted-by":"publisher","first-page":"e00883-17","DOI":"10.1128\/AAC.00883-17","volume":"61","author":"RK Shields","year":"2017","unstructured":"Shields RK, Nguyen MH, Chen L et al (2017) Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother 61:e00883-17","journal-title":"Antimicrob Agents Chemother"},{"key":"4577_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cid\/cix783","volume":"66","author":"D van Duin","year":"2018","unstructured":"van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F et al (2018) Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant enterobacteriaceae. Clin Infect Dis 66:163\u2013171. https:\/\/doi.org\/10.1093\/cid\/cix783","journal-title":"Clin Infect Dis"},{"key":"4577_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/cid\/ciy492","volume":"68","author":"M Tumbarello","year":"2019","unstructured":"Tumbarello M, Trecarichi EM, Corona A et al (2019) Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Infect Dis 68:355\u2013364","journal-title":"Clin Infect Dis"},{"key":"4577_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/jac\/dkaa503","volume":"76","author":"I Karaiskos","year":"2021","unstructured":"Karaiskos I, Daikos GL, Gkoufa A, Adamis G, Stefos A, Symbardi S et al (2021) Ceftazidime\/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study. J Antimicrob Chemother 76:775\u2013783. https:\/\/doi.org\/10.1093\/jac\/dkaa503","journal-title":"J Antimicrob Chemother"},{"key":"4577_CR13","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/jac\/dkac049","volume":"77","author":"JJ Cast\u00f3n","year":"2022","unstructured":"Cast\u00f3n JJ, Cano A, P\u00e9rez-Camacho I, Aguado JM, Carratal\u00e1 J, Ramasco F et al (2022) Impact of ceftazidime\/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing enterobacterales (CAVICOR study). J Antimicrob Chemother 77:1452\u20131460. https:\/\/doi.org\/10.1093\/jac\/dkac049","journal-title":"J Antimicrob Chemother"},{"key":"4577_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/antibiotics9070388","volume":"9","author":"M Fiore","year":"2020","unstructured":"Fiore M, Alfieri A, Di Franco S, Pace MC, Simeon V, Ingoglia G et al (2020) Ceftazidime-avibactam combination therapy compared to ceftazidime-avibactam monotherapy for the treatment of severe infections due to carbapenem-resistant pathogens: a systematic review and network meta-analysis. Antibiotics 9:388. https:\/\/doi.org\/10.3390\/antibiotics9070388","journal-title":"Antibiotics"},{"key":"4577_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s15010-021-01577-x","volume":"49","author":"S Meini","year":"2021","unstructured":"Meini S, Viaggi B, Tascini C (2021) Mono vs. combo regimens with novel beta-lactam\/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing enterobacterales: insights from the literature. Infection 49:411\u2013421. https:\/\/doi.org\/10.1007\/s15010-021-01577-x","journal-title":"Infection"},{"key":"4577_CR16","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/cid\/ciab176","volume":"73","author":"M Tumbarello","year":"2021","unstructured":"Tumbarello M, Raffaelli F, Giannella M, Mantengoli E, Mularoni A, Venditti M et al (2021) ceftazidime-avibactam use for Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae infections: a retrospective observational multicenter study. Clin Infect Dis 73:1664\u20131676. https:\/\/doi.org\/10.1093\/cid\/ciab176","journal-title":"Clin Infect Dis"},{"key":"4577_CR17","doi-asserted-by":"publisher","first-page":"e01018","DOI":"10.1128\/AAC.01018-18","volume":"62","author":"RK Shields","year":"2018","unstructured":"Shields RK, Nguyen MH, Hao B, Kline EG, Clancy CJ (2018) Colistin does not potentiate ceftazidime-avibactam killing of carbapenem-resistant enterobacteriaceae in vitro or suppress emergence of ceftazidime-avibactam resistance. Antimicrob Agents Chemother 62:e01018\u2013e01018. https:\/\/doi.org\/10.1128\/AAC.01018-18","journal-title":"Antimicrob Agents Chemother"},{"key":"4577_CR18","doi-asserted-by":"publisher","first-page":"105852","DOI":"10.1016\/j.ijantimicag.2019.11.009","volume":"55","author":"J Borjan","year":"2020","unstructured":"Borjan J, Meyer KA, Shields RK, Wenzler E (2020) Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill\/in vivo Galleria mellonella survival model analysis. Int J Antimicrob Agents 55:105852. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.11.009","journal-title":"Int J Antimicrob Agents"},{"key":"4577_CR19","unstructured":"CDC\/NHSN Surveillance definitions for specific types of infections. Available at: https:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/17pscNosInfDef_current.pdf. Accessed 22 February 2022."},{"key":"4577_CR20","unstructured":"https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_12.0_Breakpoint_Tables.pdf. Accessed 10 February 2022."},{"key":"4577_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jhin.2020.03.022","volume":"105","author":"G Bianco","year":"2020","unstructured":"Bianco G, Boattini M, van Asten SAV, Iannaccone M, Zanotto E, Zaccaria T et al (2020) RESIST-5 O.O.K.N.V. and NG-Test Carba 5 assays for the rapid detection of carbapenemase-producing enterobacterales from positive blood cultures: a comparative study. J Hosp Infect 105:162\u2013166. https:\/\/doi.org\/10.1016\/j.jhin.2020.03.022","journal-title":"J Hosp Infect"},{"key":"4577_CR22","doi-asserted-by":"publisher","first-page":"ciac354","DOI":"10.1093\/cid\/ciac354","volume":"75","author":"MJ Satlin","year":"2022","unstructured":"Satlin MJ, Chen L, Gomez-Simmonds A, Marino J, Weston G, Bhowmick T et al (2022) Impact of a rapid molecular test for Klebsiella pneumoniae carbapenemase and ceftazidime-avibactam use on outcomes after bacteremia caused by carbapenem-resistant Enterobacterales. Clin Infect Dis 75:ciac354. https:\/\/doi.org\/10.1093\/cid\/ciac354","journal-title":"Clin Infect Dis"},{"key":"4577_CR23","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/antibiotics11091226","volume":"11","author":"AF Campos","year":"2022","unstructured":"Campos AF, Arantes T, Cambiais AMVB, Cury AP, Tiroli CG, Rossi F et al (2022) Impact of an antimicrobial stewardship program intervention associated with the rapid identification of microorganisms by MALDI-TOF and detection of resistance genes in ICU patients with Gram-negative bacteremia. Antibiotics 11:1226. https:\/\/doi.org\/10.3390\/antibiotics11091226","journal-title":"Antibiotics"},{"key":"4577_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10096-021-04341-z","volume":"41","author":"G Bianco","year":"2022","unstructured":"Bianco G, Boattini M, Comini S, Iannaccone M, Bondi A, Cavallo R et al (2022) In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing enterobacterales: cross-resistance and synergistic effects. Eur J Clin Microbiol Infect Dis 41:63\u201370. https:\/\/doi.org\/10.1007\/s10096-021-04341-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4577_CR25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10096-021-04397-x","volume":"41","author":"L Poirel","year":"2022","unstructured":"Poirel L, Sadek M, Kusaksizoglu A, Nordmann P (2022) Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variants. Eur J Clin Microbiol Infect Dis 41:677\u2013680. https:\/\/doi.org\/10.1007\/s10096-021-04397-x","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4577_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhin.2022.02.001","volume":"122","author":"G Bianco","year":"2022","unstructured":"Bianco G, Boattini M, Bondi A, Comini S, Zaccaria T, Cavallo R et al (2022) Outbreak of ceftazidime-avibactam resistant Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in a COVID-19 intensive care unit, Italy: urgent need for updated diagnostic protocols of surveillance cultures. J Hosp Infect 122:217\u2013219. https:\/\/doi.org\/10.1016\/j.jhin.2022.02.001","journal-title":"J Hosp Infect"},{"key":"4577_CR27","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/jac\/dkaa079","volume":"75","author":"P Gaibani","year":"2020","unstructured":"Gaibani P, Lombardo D, Foschi C, Re MC, Ambretti S (2020) Evaluation of five carbapenemase detection assays for enterobacteriaceae harbouring blaKPC variants associated with ceftazidime\/avibactam resistance. J Antimicrob Chemother 75:2010\u20132013. https:\/\/doi.org\/10.1093\/jac\/dkaa079","journal-title":"J Antimicrob Chemother"},{"key":"4577_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jgar.2021.02.008","volume":"24","author":"G Bianco","year":"2021","unstructured":"Bianco G, Boattini M, Iannaccone M, Bondi A, Ghibaudo D, Zanotto E et al (2021) Carbapenemase detection testing in the era of ceftazidime\/avibactam-resistant KPC-producing Enterobacterales: a 2-year experience. J Glob Antimicrob Resist 24:411\u2013414. https:\/\/doi.org\/10.1016\/j.jgar.2021.02.008","journal-title":"J Glob Antimicrob Resist"},{"key":"4577_CR29","doi-asserted-by":"publisher","first-page":"e0224521","DOI":"10.1128\/jcm.02245-21","volume":"60","author":"M Hern\u00e1ndez-Garc\u00eda","year":"2022","unstructured":"Hern\u00e1ndez-Garc\u00eda M, Castillo-Polo JA, Cordero DG, P\u00e9rez-Viso B, Garc\u00eda-Castillo M, Saez de la Fuente J, Morosini MI et al (2022) Impact of ceftazidime-avibactam treatment in the emergence of novel KPC variants in the ST307-Klebsiella pneumoniae high-risk clone and consequences for their routine detection. J Clin Microbiol 60:e0224521. https:\/\/doi.org\/10.1128\/jcm.02245-21","journal-title":"J Clin Microbiol"},{"key":"4577_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","volume":"24","author":"M Falcone","year":"2020","unstructured":"Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A et al (2020) Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care 24:29. https:\/\/doi.org\/10.1186\/s13054-020-2742-9","journal-title":"Crit Care"},{"key":"4577_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","volume":"17","author":"B Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","unstructured":"Guti\u00e9rrez-Guti\u00e9rrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Pa\u00f1o-Pardo JR et al (2017) REIPI\/ESGBIS\/INCREMENT Investigators. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis 17:726\u2013734","journal-title":"Lancet Infect Dis"},{"key":"4577_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1055\/s-0039-1693704","volume":"40","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Giacobbe DR, Vena A, Wolff M (2019) Diagnosis and treatment of candidemia in the intensive care unit. Semin Respir Crit Care Med 40:524\u2013539. https:\/\/doi.org\/10.1055\/s-0039-1693704","journal-title":"Semin Respir Crit Care Med"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-023-04577-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T11:09:45Z","timestamp":1678360185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-023-04577-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["4577"],"URL":"https:\/\/doi.org\/10.1007\/s10096-023-04577-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Formal ethical approval was obtained by our Center\u2019s institutional review board (Protocol No. 0029345).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}